2022-Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients
Sitasuwan T, Phisalprapa P, Srivanichakorn W, Washirasaksiri C, Auesomwang C,Tinmanee R, Sayabovorn N, Chayakulkeeree M, Phoompoung P, Mayurasakorn K, Sookrung N, Tungtrongchitr A, Wanitphakdeedecha R, Muangman S, Senawong S,Tangjittipokin W, Sanpawitayakul G, Woradetsittichai D, Nimitpunya P,Kositamongkol C, Nopmaneejumruslers C, Vamvanij V, Chaisathaphol T. Early
antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients. Medicine (Baltimore). 2022;101(45):e31681